The advanced cancer patients with metastases orally administered with fucoidan demonstrated a significant reduction of main pro-inflammatory cytokines, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) after two weeks of fucoidan ingestion. The gene discussed is TNF; the disease is cancer.